Article
Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B.
Clinics (Sao Paulo, Brazil) - 1 Oct 2013
Angelo Ana Luiza Dias, Cavalcante Lourianne Nascimento, Abe-Sandes Kiyoko, Machado Taísa Bonfim, Lemaire Denise Carneiro, Malta Fernanda, Pinho João Renato, Lyra Luiz Guilherme Costa, Lyra Andre Castro
Abstract excerpt
OBJECTIVES: Suppressor of cytokine signaling 3, myxovirus resistance protein and osteopontin gene polymorphisms may influence the therapeutic response in patients with chronic hepatitis C, and an association with IL28 might increase the power to predict sustained virologic response. Our aims were to evaluate the association between myxovirus resistance protein, osteopontin and suppressor of cytokine signaling 3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.